A S de Leeuw1, H J G M van Megen2, R S Kahn3, H G M Westenberg3. 1. Marina de Wolfcenter, Innova, GGz Centraal, Ermelo, The Netherlands. Electronic address: a.de.leeuw@altrecht.nl. 2. Marina de Wolfcenter, Innova, GGz Centraal, Ermelo, The Netherlands. 3. Department of psychiatry, Rudolf Magnus institute of neuroscience, university medical center, Utrecht, The Netherlands.
Abstract
BACKGROUND: Preliminary studies have shown that the addition of the partial NMDA-agonist d-cycloserine (DCS) might be promising in enhancing the results of exposure therapy in obsessive-compulsive disorder (OCD). We examined the effect of DCS addition to exposure therapy in a somewhat larger sample of OCD patients with special attention to subgroups, because of the heterogeneity of OCD. METHODS: A randomized, double-blind, placebo controlled trial was conducted in 39 patients with OCD. Patients received 6 guided exposure sessions, once a week. One hour before each session 125mg DCS or placebo was administered. RESULTS: Scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) declined more in the DCS group than in the placebo group, but the difference did not reach statistical significance (P=0.076, partial η2=0.13). Response percentages also did not differ between the DCS and the placebo group (37% and 15% respectively). In the 'cleaning/contamination' subgroup a significant effect was found in favour of DCS (P=0.033, partial η2=0.297). CONCLUSIONS: The results of this study did not support the application of DCS to exposure therapy in OCD. Some specific aspects need further investigation: efficacy of DCS in a larger 'cleaning/contamination' (sub-)group, DCS addition only after successful sessions, interaction with antidepressants. Copyright Â
RCT Entities:
BACKGROUND: Preliminary studies have shown that the addition of the partial NMDA-agonist d-cycloserine (DCS) might be promising in enhancing the results of exposure therapy in obsessive-compulsive disorder (OCD). We examined the effect of DCS addition to exposure therapy in a somewhat larger sample of OCDpatients with special attention to subgroups, because of the heterogeneity of OCD. METHODS: A randomized, double-blind, placebo controlled trial was conducted in 39 patients with OCD. Patients received 6 guided exposure sessions, once a week. One hour before each session 125mg DCS or placebo was administered. RESULTS: Scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) declined more in the DCS group than in the placebo group, but the difference did not reach statistical significance (P=0.076, partial η2=0.13). Response percentages also did not differ between the DCS and the placebo group (37% and 15% respectively). In the 'cleaning/contamination' subgroup a significant effect was found in favour of DCS (P=0.033, partial η2=0.297). CONCLUSIONS: The results of this study did not support the application of DCS to exposure therapy in OCD. Some specific aspects need further investigation: efficacy of DCS in a larger 'cleaning/contamination' (sub-)group, DCS addition only after successful sessions, interaction with antidepressants. Copyright Â
Authors: David Rosenfield; Jasper A J Smits; Stefan G Hofmann; David Mataix-Cols; Lorena Fernández de la Cruz; Erik Andersson; Christian Rück; Benedetta Monzani; Ana Pérez-Vigil; Paolo Frumento; Michael Davis; Rianne A de Kleine; JoAnn Difede; Boadie W Dunlop; Lara J Farrell; Daniel Geller; Maryrose Gerardi; Adam J Guastella; Gert-Jan Hendriks; Matt G Kushner; Francis S Lee; Eric J Lenze; Cheri A Levinson; Harry McConnell; Jens Plag; Mark H Pollack; Kerry J Ressler; Thomas L Rodebaugh; Barbara O Rothbaum; Eric A Storch; Andreas Ströhle; Candyce D Tart; David F Tolin; Agnes van Minnen; Allison M Waters; Carl F Weems; Sabine Wilhelm; Katarzyna Wyka; Margaret Altemus; Page Anderson; Judith Cukor; Claudia Finck; Gary R Geffken; Fabian Golfels; Wayne K Goodman; Cassidy A Gutner; Isobel Heyman; Tanja Jovanovic; Adam B Lewin; Joseph P McNamara; Tanya K Murphy; Seth Norrholm; Paul Thuras; Cynthia Turner; Michael W Otto Journal: J Anxiety Disord Date: 2019-09-23
Authors: Gerd Kvale; Bjarne Hansen; Kristen Hagen; Jonathan S Abramowitz; Tore Børtveit; Michelle G Craske; Martin E Franklin; Svein Haseth; Joseph A Himle; Sigurd Hystad; Unn Beate Kristensen; Gunvor Launes; Anders Lund; Stian Solem; Lars-Göran Öst Journal: JAMA Netw Open Date: 2020-08-03